Detalhe da pesquisa
1.
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Haematologica
; 108(7): 1768-1781, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519325
2.
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types.
Haematologica
; 105(6): 1527-1538, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439679
3.
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.
Blood
; 130(6): 789-802, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619982
4.
The impact of RNA sequence library construction protocols on transcriptomic profiling of leukemia.
BMC Genomics
; 18(1): 629, 2017 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28818039
5.
Somatic STAT3 mutations in large granular lymphocytic leukemia.
N Engl J Med
; 366(20): 1905-13, 2012 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22591296
6.
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.
Signal Transduct Target Ther
; 8(1): 80, 2023 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843114
7.
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia.
Sci Transl Med
; 14(650): eabn3248, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731890
8.
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Cancer Discov
; 12(2): 388-401, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789538
9.
FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML.
Sci Rep
; 11(1): 23565, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876631
10.
S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.
Front Cell Dev Biol
; 9: 723016, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485305
11.
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.
Blood Adv
; 5(20): 4125-4139, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478517
12.
Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia.
Leuk Lymphoma
; 59(3): 725-732, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28776436
13.
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
Oncotarget
; 8(57): 97516-97527, 2017 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29228628
14.
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing.
Oncotarget
; 8(34): 56338-56350, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28915594
15.
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.
Leukemia
; 33(10): 2548-2553, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175323
16.
Full-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Finnish Patients from 2009 to 2013.
Genome Announc
; 2(1)2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24435855
17.
Molecular evolution and epidemiology of echovirus 6 in Finland.
Infect Genet Evol
; 16: 234-47, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462388
18.
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
Cancer Discov
; 3(12): 1416-29, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24056683